Treatment of autism spectrum disorder and associated symptoms
OwnerRichard Louis Priceinventor
Life of this patent
Estimating the term…
Abstract
Disclosed is a single unit oral dosage form having, in combination, inositol and an extended release clonidine or extended release guanfacine. In one aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient the single unit oral dosage form. In another aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient inositol in combination with extended release clonidine or extended release guanfacine, whether administered separately or as a single dosage form.
Claims12
A method for treating a patient having autism spectrum disorder (ASD), the method comprising administering to the patient at least 12,000 mg inositol per day wherein the method effectively treats part B of the DSM 5.0 definition of ASD in the patient.
A method for treating a patient having autism spectrum disorder (ASD), the method comprising administering to the patient at least 12,000 mg inositol per day, wherein the at least 12,000 mg inositol per day is provided in a single once daily unit dosage form and at least a portion of the inositol is provided in an extended release form.
Dependencies are inferred from the claim text.